Skip to main content
Caplight Logo









Meril Life Sciences

Meril Life Sciences

Private
VapiHealthcare & Life Scienceshttps://www.merillife.com/

Last Round

Private Equity

Jul 21, 2025

Est. Valuation

$6.6B

Total Funding Raised

$453M

Company Overview

Meril Life Sciences is a medical device company that designs, manufactures, and distributes clinically relevant devices for vascular intervention, orthopedics, in-vitro diagnostics, and endo-surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

medical devicestranscatheter aortic valve replacementTAVRcoronary stentorthopedic implantssurgical roboticsmedtechin-vitro diagnosticsIVDvascular interventionsurgical staplersminimally invasive surgeryrobotic surgeryinterventional cardiologyjoint replacement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Meril Life Sciences Comparables

Compare Meril Life Sciences with similar companies based on industry and business-model similarity.

Meril Life Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Edwards Lifesciences
83%
Medtronic
80%
MicroPort Scientific Corporation
78%

Meril Life Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 21, 2025
Private EquityFeb 22, 2022

Key People

Founding team and executive leadership

Vivek Shah

Chief Executive Officer

Executive Team

Meril Life Sciences Investors

Notable investors and investment history

Meril Life Sciences investors
InvestorRounds
Anchorage Capital PartnersPrivate Equity
Anchorage Capital PartnersPrivate Equity
Warburg PincusPrivate Equity
Abu Dhabi Investment AuthorityPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 21, 2025

    $200M round led by Abu Dhabi Investment Authority.

  • May 1, 2025

    Monthly visitors grew 36% MoM, reaching 77.5K.

Meril Life Sciences Filings

Explore SEC and related filing metadata, where available.

Meril Life Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about Meril Life Sciences's valuation, stock price, and market status.

Is Meril Life Sciences a public or private company?

Meril Life Sciences is a private company.

What is the current stock price of Meril Life Sciences?

Meril Life Sciences is a private company with no public stock price. Caplight tracks Meril Life Sciences's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Meril Life Sciences worth (valuation)?

Meril Life Sciences's valuation is estimated at $6.6B based on funding round data.

Can I buy Meril Life Sciences stock?

Meril Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Meril Life Sciences's last funding round?

Meril Life Sciences's most recent funding round was Private Equity on July 21, 2025.

Who are the main investors in Meril Life Sciences?

Key investors in Meril Life Sciences include Warburg Pincus, Abu Dhabi Investment Authority.

Will Meril Life Sciences IPO soon?

No public IPO plans have been announced for Meril Life Sciences.

How can I track Meril Life Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Meril Life Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVapi
Employee Range4,431
Year Founded2006
Last FundingJul 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?